Peritubular capillary flow determines tubulointerstitial disease in idiopathic nephrotic syndrome

Renal Failure

Volumn 22, Issue 3, 2000, Pages 329-335

  Futrakul, Narisa ^a   Yenrudi, Saowanee ^a   Sensirivatana, Rajanee ^a   Watana, Dhevy ^a   Laohapaibul, Aimon ^a   Watanapenphaibul, Krisda ^a   Kingwatanakul, Pornchai ^a   Futrakul, Prasit ^a   Futrakul, Sithivudh ^a  

^a KING CHULALONGKORN MEMORIAL HOSPITAL   (Thailand)

Author keywords

Hemodynamics; Nephrosis; Peritubular capillary flow; Renal perfusion; Tubulointerstitial fibrosis

Indexed keywords

ARTICLE; CAPILLARY FLOW; CORRELATION FUNCTION; GLOMERULOSCLEROSIS; HISTOPATHOLOGY; HUMAN; KIDNEY BLOOD FLOW; KIDNEY PERFUSION; MAJOR CLINICAL STUDY; NEPHROSIS; NEPHROTIC SYNDROME; PRIORITY JOURNAL;

BLOOD FLOW VELOCITY; CAPILLARIES; DRUG RESISTANCE; FEMALE; GLOMERULAR FILTRATION RATE; GLOMERULONEPHRITIS, MEMBRANOPROLIFERATIVE; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; KIDNEY TUBULES; MALE; NEPHRITIS, INTERSTITIAL; NEPHROSIS, LIPOID; NEPHROTIC SYNDROME; PROBABILITY; REFERENCE VALUES; RENAL CIRCULATION; STATISTICS, NONPARAMETRIC; STEROIDS;

EID: 0034077588     PISSN: 0886022X     EISSN: None     Source Type: Journal    
DOI: 10.1081/JDI-100100876     Document Type: Article

References (15)

1. Futrakul P, Sitprija V, Yenrudi S, Poshyachinda M, Sensirivatana R, Watana D, Singkhwa V, Jungthirapanich J, Futrakul N: Glomerular endothelial dysfunction determines disease progression : A hypothesis. Am J Nephrol 17:533-540, 1997.
2. Thomas SE, Anderson S, Gordon KL, Oyama TT, Shankland SJ, Johnson RJ: Tubulointerstitial disease in aging : Evidence for underlying peritubular apillary damage, a potential role for renal ischemia. J Am Soc Nephrol 9:231-242, 1998.
3. Futrakul P, Poshyachinda M, Futrakul N, Chaiwatanarat T, Sensirivatana R, Thamaree S, Watana D, Kingwatanakul D: Intrarenal hemodynamics alterations and tubular functions in nephrotic syndrome associated with focal segmental glomerulosclerosis (FSGS): A pathogenetic and therapeutic implication; in Andreucci VE, Dal Canton A (eds): Current Therapy in Nephrology. Milan, Wichtig 1993, pp 107-114.
4. Bohle A, Glomb D, Grund KE, Mackensen S: A correlation between relative interstitial volume of the renal cortex and serum creatinine concentration in minimal changes with nephrotic syndrome and in focal sclerosing glomerulonephritis. Virch Arch A Patho Anat Histol 376:221, 1977.
5. Futrakul P, Poshyachinda M, yenrudi S, et al: Intrarenal hemodynamic abnormality in severe form of glomerulonephritis : Therapeutic benefit with vasodilators. J Med Assoc Thai 75:375-385, 1992.
6. Bohle A, Mackensen-Haen S, Wehrmann M: Significance of postglomerular capillaries in the pathogenesis of chronic renal failure. Kidney and Blood Press Res 19:191-195, 1996.
7. Truong LD, Farhood A, Tasby J, Gillum D: Experimental chronic renal ischemia : Morphologic and immunologic studies. Kidney Int 41:1676-1689, 1992.
8. Futrakul P, Poshyachinda M, Mitrakul C: Focal sclerosing glomerulonephritis : A kinetic evaluation of hemostasis and the effect of anticoagulant therapy : A controlled study. Clin Nephrol 10:180-186, 1978.
9. Futrakul P, Futrakul N, Sitprija V: Enhanced renal perfusion improves function in severe nephrosis with focal segmental glomerulosclerosis. Nephrology 1:51-57, 1995.
10. Ito S, Yasaki T: Effect of dipyridamole treatment in proteinuria in pediatric renal disease. Nephron 44:174-179, 1980.
11. Futrakul N, Pochanugool C, Sitprija V, Singkhwa V, Futrakul P, Yenrudi S, Sensirivatana R, Watana D, Poshyachinda M: Renal dysfuncitons in glomerulonephropathy with rapidly declined renal failure. Renal Failure 18:557-565, 1996.
12. De Jong PE, vander Meer J, vander Hem GK, de Zieuw D: Is the antiproteinuric effect of dipyridamole hemodynamically mediated? Nephron 50:292-294, 1988.
13. Anderson S, Rennke HG, Brenner BM: Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in rat. J Clin Invest 77:1993-2000, 1986.
14. Stefanski A, Amann K, Ritz E: To prevent progression : Ace inhibitors, calcium antagonists or both ? Nephrol Dial Transplant 10:151-152, 1995.
15. Marinides GN, Grogged GC, Cohen AH, Border WA : Enalapril and low protein reverse chronic puromycin aminonucleoside nephropathy. Kidney Int 37:749-757, 1990.